an Editorial Board that includes Chief Editors for Clinical Research (Dr. Russell Swerdlow) and for Statistics (Dr. Ralph D'Agostino Jr.).
We live in the most exciting time in the history of clinical research. The scope and novelty of clinical research today, with new technological advances and intradisciplinary studies of human physiology and pathology, are unprecedented. Such efforts have provided numerous breakthroughs in the detection, management, treatment, and, most importantly, the prevention of many human diseases; and they have initiated starting points for the future of clinical research. BBA Clinical is intended to provide a new platform for the dissemination and furtherance of the novel and important clinical research that arises from each of these advances. Importantly, BBA Clinical will provide not just a useful forum for clinical research today: It is designed to be a prominent contributor to the larger overall body of clinical advancements far into the future, much as the original BBA journal has successfully done in the fields of biochemistry and biophysics over the past sixty-six years. 
